This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivery of Macromolecules
June 8, 2022
Digital Event8:00AM EST // 1:00PM BST // 2:00PM CEST

Guillaume Jacquot
Translational Research Manager at Vect-Horus S.A.S., France
Speaker

Profile

Dr. Guillaume JACQUOT has 20 years of experience in scientific project management and translational research in various fields, including cellular biology, virology, cardiovascular, neurobiology and cancer. His expertise extends from early discovery and hit-to-lead optimization to regulatory pharmacology and preclinical/early clinical development. He joined VECT-HORUS in 2010 where he created and manages a team dedicated to both intracellular pharmacokinetics (ICPK) profiling of molecular conjugates targeting endocytic receptors and in vivo evaluation of pharmacological properties of lead candidates. Since 2016, he is responsible for the application and optimization of VECT-HORUS’ VECTrans® drug targeting technology to therapeutics oligonucleotides.

Agenda Sessions

  • Development of Molecular Vectors for Targeted Delivery of Therapeutic Oligonucleotides

    9:40am